🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, Phase 1/2 study of oral miransertib (MK-7075) admini...
Status
Terminated
Location
Children's Hospital of Atlanta ( Site 0107)
Start Date
2017-05-16
Trial ID
NCT03094832
Treatments Being Tested
Background: Proteus syndrome (PS) is caused by a mutation in the AKT1 gene...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-11-16
Trial ID
NCT02594215
Treatments Being Tested
This is a study of the safety and tolerability of oral miransertib (MK-7075...
Status
Active Not Recruiting
Location
Children's Healthcare of Atlanta - Egleston Hospital ( Site 0107)
Start Date
2021-11-02
Trial ID
NCT04980872
Treatments Being Tested
ARQ 092 is being investigated for patients with overgrowth diseases and/or ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03317366
Treatments Being Tested
An Open-label Phase 1b Study of ARQ 092 in Combination with other Antineopl...
Status
Terminated
Location
Multiple Locations
Start Date
2015-06-09
Trial ID
NCT02476955
This is an open-label, Phase 1, dose escalation study of oral ARQ 092 admin...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01473095
Treatments Being Tested